LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today
that it will participate in the J.P. Morgan 30th Annual Healthcare
Conference on Wednesday, January 11th at 4:00 PM Pacific Time
at the Westin St. Francis in San Francisco, CA.
A live audio webcast will be available on the Company's website at www.orthofix.com
by clicking on the Investors tab and then clicking the link on the
Events & Presentations page.
About Orthofix
Orthofix International N.V. is a diversified, global medical device
company focused on developing and delivering innovative repair and
regenerative technologies to the spine and orthopedic markets.
Orthofix's products are widely distributed around the world to
orthopedic surgeons and patients via Orthofix's sales representatives
and its subsidiaries, including BREG, Inc., and via collaborations with
other leading orthopedic product companies. In addition, Orthofix is
collaborating on R&D activities with leading research and clinical
organizations such as the Musculoskeletal Transplant Foundation, the
Orthopedic Research and Education Foundation, Texas Scottish Rite
Hospital for Children, and the Cleveland Clinical Foundation. For more
information about Orthofix, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Director
of Investor Relations and Business Development
markquick@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media